Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) closed at $0.69 in the last session, down -3.28% from day before closing price of $0.71. In other words, the price has decreased by -$3.28 from its previous closing price. On the day, 2.33 million shares were traded. LXRX stock price reached its highest trading level at $0.7203 during the session, while it also had its lowest trading level at $0.69.
Ratios:
We take a closer look at LXRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.43 and its Current Ratio is at 7.45. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 17, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
On April 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $5.
On March 07, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $3.Jefferies initiated its Hold rating on March 07, 2023, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when COATS LONNEL bought 300,000 shares for $1.60 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LXRX now has a Market Capitalization of 249429472 and an Enterprise Value of 90955480. For the stock, the TTM Price-to-Sale (P/S) ratio is 47.69 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 17.394 whereas that against EBITDA is -0.432.
Stock Price History:
The Beta on a monthly basis for LXRX is 1.05, which has changed by -0.5 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, LXRX has reached a high of $3.73, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -18.55%, while the 200-Day Moving Average is calculated to be -55.37%.
Shares Statistics:
According to the various share statistics, LXRX traded on average about 4.84M shares per day over the past 3-months and 5470310 shares per day over the past 10 days. A total of 361.49M shares are outstanding, with a floating share count of 168.72M. Insiders hold about 53.33% of the company’s shares, while institutions hold 29.69% stake in the company. Shares short for LXRX as of 1735603200 were 33499569 with a Short Ratio of 6.93, compared to 1732838400 on 31530008. Therefore, it implies a Short% of Shares Outstanding of 33499569 and a Short% of Float of 20.549999.
